NCT07431281: Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- State
- Under way
- Phase
- Phase 3
- People
- 2,130 planned
- Started
- 3 Feb 2026
- Primary completion
- 16 Aug 2029
- Arms
- Arm A
- Results
- None posted
- 3 Feb 2026: Trial started
- 24 Feb 2026: Trial registered